Figure 2. T cells and antibodies recognizing antigens shared between cancer cells and normal skin cells drive autoimmune-mediated cutaneous adverse events.

Melanoma and non-small cell lung cancer (NSCLC) may elicit autoreactive T cells and autoantibodies that attack melanocytes and keratinocytes.